Allurion Technologies Inc. (ALUR) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Allurion Technologies Inc... (ALUR)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.43

0.29 (9.24%)

At close: Jan 15, 2025, 12:28 PM

undefined% (undefined)

Bid	3.2
Market Cap	9.31M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-10.25
PE Ratio (ttm)	-0.33
Forward PE	n/a
Analyst	Buy

Ask	3.49
Volume	56,034
Avg. Volume (20D)	38,564
Open	3.13
Previous Close	3.14
Day's Range	3.00 - 3.43
52-Week Range	2.72 - 98.75
Beta	undefined

About ALUR

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite....

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Mar 29, 2021

Employees 501

Stock Exchange NYSE

Ticker Symbol ALUR

Website https://www.allurion.com

Analyst Forecast

According to 4 analyst ratings, the average rating for ALUR stock is "Buy." The 12-month stock price forecast is $50, which is an increase of 1356.88% from the latest price.

Buy 75.00%

Hold 25.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Allurion Technologies Inc. is scheduled to release its earnings on Mar 20, 2025, before market opens.
Analysts project revenue of $5.57M, reflecting a -32.36% YoY shrinking and earnings per share of -0.24, making a -40.00% decrease YoY.

Why Price Moved

5 days ago · Source

-47.24%

Shares of companies within the broader consumer di... Unlock content with Pro Subscription

2 months ago · Source

-14.3%

Allurion Technologies shares are trading lower after Chardan Capital downgraded the stock from Buy to Neutral.

News

1 day ago · businesswire.com

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a subscription a...

3 weeks ago · businesswire.com

Allurion Technologies, Inc. Announces Reverse Stock Split

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that its Board of Directors has determine...

1 month ago · businesswire.com

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it received an Acceptance Letter from the List...

1 month ago · businesswire.com

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the launch of AllurionMeds, a unique offering to pa...

2 months ago · seekingalpha.com

Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript

Allurion Technologies Inc. (NYSE:ALUR ) Q3 2024 Earnings Conference Call November 13, 2024 8:30 AM ET Company Participants Mike Cavanaugh – Investor Relations Shantanu Gaur – Founder and Chief Executi...

2 months ago · businesswire.com

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it will report financial results for...

2 months ago · zacks.com

ALUR Stock Declines Despite Submitting PMA for Allurion Balloon

Allurion submits the first three modules of PMA application to the FDA for the Allurion Balloon.